Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer

[1]  L. Tentori,et al.  Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin , 2015, International journal of cancer.

[2]  Min Liu,et al.  MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells. , 2014, Cancer letters.

[3]  P. Dayton,et al.  Vascular channels formed by subpopulations of PECAM1+ melanoma cells , 2014, Nature Communications.

[4]  Peng Cheng,et al.  Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway. , 2014, Molecular medicine reports.

[5]  C. Bouzigues,et al.  Regulation of the ROS response dynamics and organization to PDGF motile stimuli revealed by single nanoparticle imaging. , 2014, Chemistry & biology.

[6]  Z. Fu,et al.  Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling. , 2014, Cancer letters.

[7]  Jerzy Robert Ładny,et al.  The diagnostics of colorectal cancer , 2013, Contemporary oncology.

[8]  J. Sabourin,et al.  Colorectal carcinomas in 2013: the search for powerful prognostic markers is still on the go! , 2014, Cancer biomarkers : section A of Disease markers.

[9]  Hao Wang,et al.  Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells’ survival by protecting cells from oxidative stress , 2014, Molecular and Cellular Biochemistry.

[10]  Y. Liu,et al.  Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Plays a Key Role in Vasculogenic Mimicry Formation, Neovascularization and Tumor Initiation by Glioma Stem-like Cells , 2013, PloS one.

[11]  Han-Suk Kim,et al.  Oxidative stress and the antioxidant enzyme system in the developing brain , 2013, Korean journal of pediatrics.

[12]  Ping Chen,et al.  Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis , 2013, Medical Oncology.

[13]  Shafiq A. Khan,et al.  Vascular endothelial growth factor A, secreted in response to transforming growth factor-β1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells. , 2012, Asian journal of andrology.

[14]  A. Faussat,et al.  Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions. , 2012, European journal of pharmacology.

[15]  R. Shao,et al.  Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation* , 2012, The Journal of Biological Chemistry.

[16]  Xue Leng,et al.  Zinc finger E‐box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial‐to‐mesenchymal transition , 2012, Cancer science.

[17]  Chulhee Choi,et al.  Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. , 2011, Molecular cell.

[18]  R. Shao,et al.  A Matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells. , 2011, Journal of visualized experiments : JoVE.

[19]  M. Neurath,et al.  VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer , 2010, The Journal of experimental medicine.

[20]  S. Ahmadi,et al.  Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. , 2010, Archives of Iranian medicine.

[21]  Dae-Yeul Yu,et al.  Inactivation of Peroxiredoxin I by Phosphorylation Allows Localized H2O2 Accumulation for Cell Signaling , 2010, Cell.

[22]  Bao-cun Sun,et al.  Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry , 2010, Hepatology.

[23]  D. Sargent,et al.  Revised TN categorization for colon cancer based on national survival outcomes data. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  H. Haapasalo,et al.  Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors , 2010, BMC Cancer.

[25]  P. Pauwels,et al.  Prognostic Role of Vasculogenic Mimicry in Colorectal Cancer , 2009, Diseases of the colon and rectum.

[26]  Bao-cun Sun,et al.  Functional significance of VEGF-a in human ovarian carcinoma: Role in vasculogenic mimicry , 2008, Cancer biology & therapy.

[27]  Baocun Sun,et al.  Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. , 2008, Human pathology.

[28]  Baocun Sun,et al.  Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. , 2007, Cancer letters.

[29]  Sang Won Kang,et al.  Peroxiredoxins in breast carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.